Treating Reflux Esophagitis: A 41-Year-Old Man's Successful Recovery with Two Medications
Overview: A 41-year-old male patient experienced symptoms such as heartburn, chest tightness, and acid regurgitation for approximately three years. Initially misdiagnosed or improperly treated at a local hospital, he eventually sought care at our facility where he was accurately diagnosed with reflux esophagitis—a common condition involving irritation of the esophagus due to stomach acid backflow. After receiving targeted treatment including intravenous and oral medications, his symptoms significantly improved, and he regained quality sleep and overall well-being.
Patient Profile:
- Age: 41
- Gender: Male
- Diagnosis: Reflux Esophagitis
- Treatment Facility: The 988th Hospital of the Joint Logistics Support Force
- Visit Date: September 2021
- Treatment Plan: Intravenous administration of Revaprazan (Rabeprazole Sodium for Injection) combined with oral Mosapride Citrate Tablets
- Treatment Duration: 5 days of inpatient care followed by six months of outpatient follow-up
- Outcome: Complete resolution of palpitations, chest discomfort, and acid reflux; improved mental state and nighttime sleep
Initial Consultation:
The patient reported recurring episodes of chest discomfort and acid reflux primarily at night, accompanied by occasional coughing. Despite undergoing cardiac tests like coronary angiography and Holter monitoring at his local clinic—both showing no abnormalities—his symptoms persisted and even worsened over time. Upon detailed review of his medical history, it was determined that his long-standing hepatitis B had been stable, ruling out hepatic or biliary causes. A barium swallow test confirmed the presence of gastroesophageal reflux disease (GERD), leading to a diagnosis of reflux esophagitis.
Course of Treatment:
For nearly three years, the patient endured intermittent heart palpitations and anxiety, fearing a potential cardiac event. A gastroscopy revealed linear red mucosal lesions just above the gastroesophageal junction, confirming the diagnosis of reflux esophagitis. He was prescribed Rabeprazole Sodium to reduce gastric acid production and Mosapride Citrate to enhance gastrointestinal motility. Alongside pharmacological therapy, psychological counseling played a crucial role in alleviating his stress and improving symptom relief. Over time, his physical discomfort diminished, and his emotional health improved significantly.
Results and Recovery:
Within five days of treatment, the patient's symptoms—including acid reflux, chest pain, and palpitations—markedly decreased. His mood stabilized, and he began sleeping better at night. With no signs of fever or persistent cough, he was discharged after a short hospital stay and continued on an outpatient follow-up plan for six months.
Post-Treatment Lifestyle Recommendations:
To prevent recurrence and maintain digestive health, patients should consider adopting the following lifestyle modifications:
1. Avoid overeating and refrain from lying down immediately after meals; wait at least 2–3 hours before bedtime.
2. Eliminate smoking and alcohol consumption; avoid spicy foods, caffeine, and fatty meals.
3. Maintain a healthy weight and manage conditions that increase abdominal pressure, such as chronic constipation or persistent coughing.
4. Practice stress management techniques and seek prompt medical attention if symptoms reappear.
Clinical Insights:
Reflux esophagitis occurs when stomach or duodenal contents flow back into the esophagus, causing inflammation and discomfort. Common manifestations include heartburn, upper abdominal pain, and chest tightness. In some cases, patients may experience atypical symptoms such as palpitations, especially after eating or during the night. Risk factors include obesity, chronic stress, smoking, and excessive alcohol use. With proper awareness and preventive measures, this condition can be effectively managed and often avoided altogether.